ICPT Annual FCF
-$27.35 M
+$14.12 M+34.04%
31 December 2022
Summary:
As of February 5, 2025, ICPT annual free cash flow is -$27.35 million, with the most recent change of +$14.12 million (+34.04%) on December 31, 2022. During the last 3 years, it has risen by +$210.40 million (+88.50%).ICPT Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ICPT Quarterly FCF
$16.67 M
+$40.07 M+171.25%
30 September 2023
Summary:
As of February 5, 2025, ICPT quarterly free cash flow is $16.67 million, with the most recent change of +$40.07 million (+171.25%) on September 30, 2023. Over the past year, it has increased by +$33.59 million (+198.53%).ICPT Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ICPT TTM FCF
-$62.83 M
+$33.59 M+34.84%
30 September 2023
Summary:
As of February 5, 2025, ICPT TTM free cash flow is -$62.83 million, with the most recent change of +$33.59 million (+34.84%) on September 30, 2023. Over the past year, it has dropped by -$45.17 million (-255.71%).ICPT TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ICPT Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +34.0% | +198.5% | -255.7% |
| 3 y3 years | +88.5% | +139.9% | +71.0% |
| 5 y5 years | +90.1% | +132.3% | +73.6% |
ICPT Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -1175.4% | at high | -2328.1% |
Intercept Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $16.67 M(-171.3%) | -$62.83 M(-34.8%) |
| June 2023 | - | -$23.40 M(-54.6%) | -$96.43 M(+64.0%) |
| Mar 2023 | - | -$51.60 M(+1044.3%) | -$58.81 M(+115.1%) |
| Dec 2022 | -$27.35 M(-34.0%) | -$4.51 M(-73.4%) | -$27.35 M(+54.8%) |
| Sept 2022 | - | -$16.92 M(-219.1%) | -$17.66 M(-726.4%) |
| June 2022 | - | $14.21 M(-170.6%) | $2.82 M(-142.9%) |
| Mar 2022 | - | -$20.13 M(-489.0%) | -$6.57 M(-84.2%) |
| Dec 2021 | -$41.46 M(-76.4%) | $5.17 M(+45.3%) | -$41.46 M(-37.5%) |
| Sept 2021 | - | $3.56 M(-26.2%) | -$66.35 M(-40.6%) |
| June 2021 | - | $4.83 M(-108.8%) | -$111.72 M(-15.1%) |
| Mar 2021 | - | -$55.03 M(+179.1%) | -$131.62 M(-25.1%) |
| Dec 2020 | -$175.75 M(-26.1%) | -$19.71 M(-52.8%) | -$175.75 M(-18.9%) |
| Sept 2020 | - | -$41.81 M(+177.5%) | -$216.62 M(-2.2%) |
| June 2020 | - | -$15.07 M(-84.8%) | -$221.58 M(-12.3%) |
| Mar 2020 | - | -$99.16 M(+63.7%) | -$252.75 M(+6.3%) |
| Dec 2019 | -$237.75 M(-1.3%) | -$60.58 M(+29.5%) | -$237.75 M(+3.3%) |
| Sept 2019 | - | -$46.77 M(+1.2%) | -$230.10 M(-2.0%) |
| June 2019 | - | -$46.24 M(-45.1%) | -$234.91 M(-0.5%) |
| Mar 2019 | - | -$84.16 M(+59.0%) | -$236.08 M(-2.0%) |
| Dec 2018 | -$240.88 M(-12.7%) | -$52.93 M(+2.6%) | -$240.88 M(-9.0%) |
| Sept 2018 | - | -$51.58 M(+8.8%) | -$264.70 M(-2.4%) |
| June 2018 | - | -$47.41 M(-46.7%) | -$271.12 M(-4.3%) |
| Mar 2018 | - | -$88.95 M(+15.9%) | -$283.22 M(+2.7%) |
| Dec 2017 | -$275.79 M | -$76.75 M(+32.3%) | -$275.79 M(-4.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | -$58.00 M(-2.5%) | -$289.58 M(-15.7%) |
| June 2017 | - | -$59.52 M(-27.0%) | -$343.50 M(-3.7%) |
| Mar 2017 | - | -$81.53 M(-10.0%) | -$356.78 M(+2.7%) |
| Dec 2016 | -$347.52 M(+105.8%) | -$90.54 M(-19.1%) | -$347.52 M(+7.5%) |
| Sept 2016 | - | -$111.92 M(+53.7%) | -$323.19 M(+31.3%) |
| June 2016 | - | -$72.80 M(+0.7%) | -$246.13 M(+17.4%) |
| Mar 2016 | - | -$72.26 M(+9.1%) | -$209.58 M(+24.1%) |
| Dec 2015 | -$168.84 M(+82.8%) | -$66.21 M(+90.0%) | -$168.84 M(+24.4%) |
| Sept 2015 | - | -$34.86 M(-3.8%) | -$135.72 M(+6.2%) |
| June 2015 | - | -$36.25 M(+15.0%) | -$127.80 M(+14.8%) |
| Mar 2015 | - | -$31.52 M(-4.8%) | -$111.29 M(+20.5%) |
| Dec 2014 | -$92.38 M(+211.7%) | -$33.10 M(+22.9%) | -$92.38 M(+29.7%) |
| Sept 2014 | - | -$26.93 M(+36.5%) | -$71.22 M(+40.2%) |
| June 2014 | - | -$19.73 M(+56.4%) | -$50.80 M(+38.8%) |
| Mar 2014 | - | -$12.62 M(+5.7%) | -$36.61 M(+23.5%) |
| Dec 2013 | -$29.64 M(+87.7%) | -$11.93 M(+83.1%) | -$29.64 M(+34.6%) |
| Sept 2013 | - | -$6.52 M(+17.7%) | -$22.01 M(+14.7%) |
| June 2013 | - | -$5.54 M(-1.9%) | -$19.18 M(+9.5%) |
| Mar 2013 | - | -$5.64 M(+31.1%) | -$17.52 M(+11.0%) |
| Dec 2012 | -$15.79 M(-720.9%) | -$4.31 M(+16.6%) | -$15.79 M(+37.5%) |
| Sept 2012 | - | -$3.69 M(-4.6%) | -$11.48 M(+47.4%) |
| June 2012 | - | -$3.87 M(-1.0%) | -$7.79 M(+99.0%) |
| Mar 2012 | - | -$3.91 M | -$3.91 M |
| Dec 2011 | $2.54 M(-118.6%) | - | - |
| Dec 2010 | -$13.69 M | - | - |
FAQ
- What is Intercept Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals annual FCF year-on-year change?
- What is Intercept Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals quarterly FCF year-on-year change?
- What is Intercept Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals TTM FCF year-on-year change?
What is Intercept Pharmaceuticals annual free cash flow?
The current annual FCF of ICPT is -$27.35 M
What is the all time high annual FCF for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high annual free cash flow is $2.54 M
What is Intercept Pharmaceuticals annual FCF year-on-year change?
Over the past year, ICPT annual free cash flow has changed by +$14.12 M (+34.04%)
What is Intercept Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of ICPT is $16.67 M
What is the all time high quarterly FCF for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high quarterly free cash flow is $16.67 M
What is Intercept Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, ICPT quarterly free cash flow has changed by +$33.59 M (+198.53%)
What is Intercept Pharmaceuticals TTM free cash flow?
The current TTM FCF of ICPT is -$62.83 M
What is the all time high TTM FCF for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high TTM free cash flow is $2.82 M
What is Intercept Pharmaceuticals TTM FCF year-on-year change?
Over the past year, ICPT TTM free cash flow has changed by -$45.17 M (-255.71%)